Effect of quercetin in Hoechst 33342 transport by purified and reconstituted P-glycoprotein

Biochemical Pharmacology

Volumn 53, Issue 4, 1997, Pages 587-596

  Shapiro, Adam B ^a   Ling, Victor ^a,b  

^a UNIVERSITY OF TORONTO   (Canada)

^b BRITISH COLUMBIA CANCER RESEARCH CENTRE   (Canada)

Author keywords

7,12 dimethylbenz a anthracene; Adriamycin; Hoechst 33342; multidrug resistance; P glycoprotein; quercetin

Indexed keywords

7,12 DIMETHYLBENZ[A]ANTHRACENE; DOXORUBICIN; GLYCOPROTEIN P; HOE 33342; QUERCETIN;

ANIMAL CELL; ARTICLE; CHEMOSENSITIVITY; CONTROLLED STUDY; DRUG MECHANISM; DRUG TRANSPORT; FLUORESCENCE; IN VITRO STUDY; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN PURIFICATION;

ADENOSINE TRIPHOSPHATASES; ADENOSINE TRIPHOSPHATE; ANIMALS; BENZIMIDAZOLES; BIOLOGICAL TRANSPORT; CHO CELLS; CRICETINAE; HYDROLYSIS; P-GLYCOPROTEIN; QUERCETIN;

EID: 0031581819     PISSN: 00062952     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-2952(96)00826-X     Document Type: Article

References (29)

1. 1. Childs S and Ling V, The MDR superfamily of genes and its biological implications. In: Important Advances in Oncology 1994 (Eds. DeVita VT, Hellman S and Rosenberg JB), pp. 21-36. J. B. Lippincott Co., Philadelphia, 1994.
2. 2. Endicott JA and Ling V, The biochemistry of P-glycoprotein-mediated multidrug resistance. Annu Rev Biochem 58: 137-171, 1989.
3. 3. Gottesman MM and Pastan I, Biochemistry of multidrug resistance mediated by the multidrug transporter. Annu Rev Biochem 62: 385-427, 1993.
4. 4. Higgins CF, ABC transporters: From microorganisms to man. Annu Rev Cell Biol 8: 67-113, 1992.
5. 5. Doige CA and Ames GF-L, ATP-dependent transport systems in bacteria and humans: Relevance to cystic fibrosis and multidrug resistance. Annu Rev Microbiol 47: 291-319, 1993.
6. 6. Shapiro AB and Ling V, Reconstitution of drug transport by purified P-glycoprotein. J Biol Chem 270: 16167-16175, 1995.
7. 7. Phang JM, Poore CM, Lopaczynska J and Yeh GC, Flavonol-stimulated efflux of 7,12-dimethylbenz(a)anthracene in multidrug-resistant breast cancer cells. Cancer Res 53: 5977-5981, 1993.
8. 8. Critchfield JW, Welsh CJ, Phang JM and Yeh GC, Modulation of Adriamycin accumulation and efflux by flavonoids in HCT-15 colon cells: Activation of P-glycoprotein as a putative mechanism. Biochem Pharmacol 48: 1437-1445, 1994.
9. 9. Scambia G, Ranelletti FO, Panici PB, DeVincenzo R, Bonanno G, Ferrandina G, Piantelli M, Bussa S, Rumi C, Cianfriglia M and Mancuso S, Quercetin potentiates the effect of Adriamycin in a multidrug-resistant MCF-7 human breast cancer cell line: P-glycoprotein as a possible target. Cancer Chemother Pharmacol 34: 459-464, 1994.
10. 10. Akiyama T and Ogawara H, Use and specificity of genistein as inhibitor of protein-tyrosine kinases. Methods Enzymol 201: 363-370, 1991.
11. 11. Shisheva A and Shechter Y, Quercetin selectively inhibits insulin receptor function in vitro and the bioresponses of insulin and insulinomimetic agents in rat adipocytes. Biochemistry 31: 8059-8063, 1992.
12. 2 by quercetin. Inflammation 17: 573-582, 1993.
13. 13. Merlos M, Sanchez RM, Camaras J and Adzet T, Flavonoids as inhibitors of rat liver cytosolic glutathione-S-transferase. Experientia 47: 616-619, 1991.
14. 14. Bors W, Heller W, Michel C and Saran M, Flavonoids as antioxidants; Determination of radical-scavenging efficiencies. Methods Enzymol 186: 343-355, 1990.
15. 15. Elia G and Santoro MG, Regulation of heat shock protein synthesis by quercetin in human erythroleukemia cells. Biochem J 300: 201-209, 1994.
16. 16. Chiesi M and Schwaller R, Inhibition of constitutive endothelial NO-synthase activity by tannin and quercetin. Biochem Pharmacol 49: 495-501, 1995.
17. 17. Chen AY, Yu C, Bodley A, Peng LF and Liu LF, A new mammalian DNA topoisomerase I poison Hoechst 33342: Cytotoxicity and drug resistance in human cell cultures. Cancer Res 53: 1332-1337, 1993.
18. 18. Lalande ME, Ling V and Miller RG, Hoechst 33342 dye uptake as a probe of membrane permeability changes in mammalian cells. Proc Natl Acad Sci USA 78: 363-367, 1981.
19. 19. Shapiro AB and Ling V, ATPase activity of purified and reconstituted P-glycoprotein from Chinese hamster ovary cells. J Biol Chem 269: 3745-3754, 1994.
20. 20. Georges E, Zhang J-T and Ling V, Modulation of ATP and drug binding by monoclonal antibodies against P-glycoprotein. J Cell Physiol 148: 479-484, 1991.
21. 21. Ling V and Thompson LH, Reduced permeability in CHO cells as a mechanism of resistance to colchicine. J Cell Physiol 83: 103-116, 1974.
22. 22. Bech-Hansen NJ, Till JE and Ling V, Pleiotropic phenotype of colchicine-resistant CHO cells: Cross-resistance and collateral sensitivity. J Cell Physiol 88: 23-31, 1976.
23. 23. Riordan JR, Deuchars K, Kartner N, Alon N, Trent J and Ling V, Amplification of P-glycoprotein genes in multidrug resistant mammalian cell lines. Nature 316: 817-819, 1985.
24. 24. Juliano RL and Ling V, A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants. Biochim Biophys Acta 455: 152-162, 1976.
25. 25. Schuurhuis GJ, van Heijningen THM, Cervantes A, Pinedo HM, de Lange JHM, Keizer HG, Broxterman HJ, Baak JPA and Lankelma J, Changes in subcellular doxorubicin distribution and cellular accumulation alone can largely account for doxorubicin resistance in SW-1573 lung cancer and MCF-7 breast cancer multidrug resistant tumour cells. Br J Cancer 68: 898-908, 1993.
26. 26. Lakowicz JR, Principles of Fluorescence Spectroscopy, Chap. 9. Plenum Press, New York, 1983.
27. 27. Sharom FJ, Yu X and Doige CA, Functional reconstitution of drug transport and ATPase activity in proteoliposomes containing partially purified P-glycoprotein. J Biol Chem 268: 24197-24202, 1993.
28. 28. Ruetz S, Raymond M and Gros P, Functional expression of P-glycoprotein encoded by the mouse mdr3 gene in yeast cells. Proc Natl Acad Sci USA 90: 11588-11592, 1993.
29. 29. Tamai I and Safa AR, Azidopine noncompetitively interacts with vinblastine and cyclosporin A binding to P-glycoprotein in multidrug resistant cells. J Biol Chem 266: 16796-16800, 1991.